Phosphate Transport in Yeast Vacuoles*

(Received for publication, March 7, 1997, and in revised form, June 6, 1997)

James W. Booth Dagger and Guido Guidotti

From the Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The vacuole of the yeast Saccharomyces cerevisiae is a major storage compartment for phosphate. We have measured phosphate transport across the vacuolar membrane. Isolated intact vacuoles take up large amounts of added [32P]phosphate by counterflow exchange with phosphate present in the vacuoles at the time of their isolation. The bidirectional phosphate transporter has an intrinsic dissociation constant for phosphate of 0.4 mM. Exchange mediated by this carrier is faster than unidirectional efflux of phosphate from the vacuoles. The transporter is highly selective for phosphate; of other anions tested, only arsenate is also a substrate. Transport is strongly pH-dependent with increasing activity at lower pH. Similar phosphate transport behavior was observed in right-side-out vacuolar membrane vesicles.


INTRODUCTION

Phosphate is an important nutrient, and phosphate metabolism in the yeast Saccharomyces cerevisiae has been extensively studied. This system has provided a model for understanding how a cell makes a coordinated response to environmental changes (1). Phosphate is often present in only low amounts in the environment (2), and as for other microorganisms, yeast has evolved complex mechanisms to deal with changes in phosphate availability.

One aspect of phosphate metabolism in yeast which has received substantial attention is the question of how the cell obtains phosphate from its surroundings. Several secreted phosphatases which release free phosphate in the extracellular space have been identified (3). Uptake of free phosphate from outside the cell is mediated by a number of plasma membrane transport systems. One has a high affinity for phosphate and is encoded by the PHO84 gene, whose expression is derepressed under conditions of phosphate starvation (4). Others include a sodium/phosphate cotransporter and a low affinity, constitutive transport system (5, 6).

Once phosphate has been taken up by the yeast cell, a second important consideration is its intracellular compartmentalization. In this respect the yeast vacuole plays a major role. The vacuole is the site of storage of large amounts of phosphate and polyphosphate, a linear polymer of phosphate in anhydrous linkage (7-9). These vacuolar pools are either augmented or depleted depending on changes in phosphate availability (2, 10, 11). This process clearly entails net movements of phosphate across the vacuolar membrane. However, in contrast to the situation with the plasma membrane, no phosphate transport system in the vacuolar membrane has yet been characterized.

A variety of different substances are concentrated in the yeast vacuole (12), and numerous vacuolar transport systems have been described. These include transporters of protons (13), Ca2+ (14, 15), amino acids (16, 17), K+ and Na+ (18, 19), polyamines (20), glutathione S-conjugates (21), S-adenosylmethionine (22), purines (23), and chloride (24). Phosphate and polyphosphate are major vacuolar anions, with a large buffering capacity. Thus, understanding vacuolar phosphate transport is also important for understanding the storage functions of the vacuole in terms of overall charge balance, vacuolar acidification, and osmoregulation.

We have measured transport of phosphate across the vacuolar membrane by performing transport assays with isolated intact vacuoles and vacuolar membrane vesicles. Counterflow behavior is observed indicative of a reversible phosphate transporter with a millimolar affinity for phosphate. This transporter is highly specific for phosphate.


EXPERIMENTAL PROCEDURES

Yeast Strains and Materials

Yeast strain ATCC 32167 was used for all vacuole preparations. 32P-Labeled orthophosphate, pyrophosphate, and ATP were obtained from NEN Life Sciences Products. Lyticase was Sigma L-8012 and melting point bath oil was Sigma M-9389, rho  = 1.05. Nitrocellulose filters were from Millipore. Bafilomycin A1 was kindly provided by Dr. Hans-Peter Feidler of the University of Tübingen.

Isolation and Purification of Vacuoles

Vacuoles were purified under isotonic conditions. Preparation and lysis of spheroplasts was performed as described previously (25) with the following modifications. Cells were grown in SD media (Difco) supplemented with 7 mM potassium phosphate, 50 mM sodium citrate, pH 5.1. Spheroplasting was performed with lyticase (1700 units/g wet weight of cells). Osmotic stabilization was provided by 0.6 M sorbitol or sucrose buffered with 5 mM Tris-PIPES,1 pH 6.9. Vacuoles were purified from spheroplast lysate in two steps by density gradient centrifugation (26). The first gradient consisted of a bottom layer of buffered sucrose plus 2.5% Ficoll, a middle layer of a 2:1 mixture of buffered sorbitol and sucrose, and cell lysate on top. After centrifugation for 1 h at 75,000 × g the crude vacuoles were collected from the interface between the bottom two layers, diluted with 3 volumes of buffered sorbitol, then spun for 45 min at 3,500 × g over a 2:1 mixture of buffered sorbitol and sucrose. Purified vacuoles were obtained in the pellet and resuspended in a small volume of buffered sorbitol on ice. Vacuole suspensions were counted in a hemocytometer, then stored on ice overnight and used the next day.

Analysis of Vacuolar Contents

Phosphate was measured as described previously (27); polyphosphate was measured as orthophosphate released after boiling in 1 N H2SO4 for 10 min.

Vacuolar Transport Assays

We developed a new method for measuring transport in isolated intact vacuoles which we found more convenient than that described previously (25). Vacuoles were diluted to a concentration of 4 × 108/ml in ice-cold 0.6 M sorbitol, 5 mM Tris-PIPES, pH 6.5, shortly before the experiment. At time 0, the diluted vacuoles were added to an equal volume of 25 °C buffered sorbitol containing [32P]phosphate (10 µCi/ml) plus any additions and then incubated in a water bath at 25 °C. The total concentration of phosphate outside the vacuoles under these conditions is 50-200 µM, arising from phosphate released from the vacuoles. At time points, 100-µl aliquots of the vacuole suspension were removed, layered in a narrow tube (Sarstedt 72-701) over a 6:1 mixture of melting point bath oil:dinonyl pthallate, and spun in a Beckman microcentrifuge for 1 min. The vacuoles sediment through the oil mixture. The bottoms of the tubes were then frozen, cut off, and transferred to scintillation vials. 0.5 ml of 1% SDS was added to each vial and the vials were agitated on a Vortex mixer for 10 s. Radioactivity associated with the vacuoles was determined by liquid scintillation counting with Ecoscint in a Beckman LS-1011 scintillation counter.

Carrier Model

To construct theoretical counterflow and efflux curves, a simple mobile carrier model was used (28). The carrier was described in terms of four parameters: K, the intrinsic dissociation constant of the carrier for phosphate, and R12, R21, and Ree, "resistance" terms given by the reciprocals of Vmax for zero-trans or equilibrium exchange experiments, with side 1 as the inside of the vacuole. Equations giving the predicted rates of change of both [32P]phosphate and total phosphate inside the vacuole as functions of these parameters were derived. These predicted velocities were computed at 3-s intervals using Microsoft Excel 7.0, and used to generate model curves.

Vacuolar Membrane Vesicles

Vacuolar membrane vesicles were prepared as described previously (29). For uptake experiments, radioactivity in vesicles trapped on filters was determined by liquid scintillation counting with Ecoscint in a Beckman LS-1011 scintillation counter.


RESULTS

Uptake of [32P]Phosphate into Isolated Intact Vacuoles

We observe that dilution of purified intact vacuoles into buffer containing tracer [32P]phosphate results in uptake of radioactivity into the vacuoles (Fig. 1). The vacuole-associated radioactivity displays a distinctive time course that is reproducible between vacuole preparations (n = 10). Initially there is net uptake of [32P]phosphate, leading in 7-10 min to a peak that corresponds to internalization of 3-8% of the total added radioactivity. This represents a 20-60-fold concentration of [32P]phosphate within the vacuoles. Subsequently, net efflux of [32P]phosphate from the vacuoles occurs, such that by the 30-min time point most of the radioactivity is released.


Fig. 1. Uptake of [32P]phosphate by yeast vacuoles. Uptake of [32P]phosphate by isolated intact yeast vacuoles was measured as described under "Experimental Procedures." The two sets of points (square  and black-diamond ) are from independent experiments with vacuoles from the same preparation. Curves of a similar shape and peak height were obtained in experiments with vacuoles from 10 different preparations.
[View Larger Version of this Image (16K GIF file)]

The shape of this curve suggests that [32P]phosphate is being taken up by counterflow. Counterflow is a hallmark of carrier-mediated transport (28). Movement of one species against its concentration gradient is driven by the flow in the opposite direction of a second species through a carrier common to both. Vacuoles contain large amounts of polyphosphate (8), and also can contain high concentrations of orthophosphate (7). Phosphate may also be formed by hydrolysis of polyphosphate during purification of the vacuoles. Vacuoles isolated under isotonic conditions largely retain their contents during purification (30). Thus, the simplest explanation for the observed uptake of labeled phosphate is that it is mediated by a phosphate carrier in the vacuolar membrane, and is coupled to net efflux of phosphate from the vacuoles through this carrier.

We confirmed that there is indeed net movement of phosphate out of the vacuoles down its concentration gradient upon dilution of the vacuoles (Fig. 2A). The total amount of orthophosphate in the vacuole suspension also increases throughout the incubation, presumably due to hydrolysis of polyphosphate or other phosphorylated vacuolar constituents. Similar observations were made by Dürr et al. (31). Polyphosphate is present in much higher amounts than phosphate (Fig. 2B), so a decrease in vacuolar polyphosphate due to hydrolysis is difficult to observe. However, the high recovery of polyphosphate in the vacuoles throughout the incubation does serve to indicate that there is no substantial loss of vacuoles due to lysis.


Fig. 2. Release of phosphate and polyphosphate from isolated vacuoles. Vacuoles were diluted to a concentration of 4 × 108/ml in 0.6 M sorbitol, 5 mM Tris-PIPES, pH 6.9, and incubated at 25 °C. At time points 100-µl aliquots were removed. The entire aliquot was frozen rapidly on dry ice (for measurement of suspension totals) or vacuoles were removed by centrifugation and the supernatants collected and immediately frozen (for measurement of release of contents). Tubes were later thawed by incubation for 10 min in a boiling water bath before assay of phosphate (A) and polyphosphate (B). Total in the suspension, square ; released in the supernatant, black-diamond . Phosphate or polyphosphate inside the vacuoles (+) was calculated as the difference between the total in the suspension and the amount released. Similar results were obtained with two different vacuole preparations.
[View Larger Version of this Image (15K GIF file)]

As can be observed by comparison of Figs. 1 and 2, the total orthophosphate inside isolated vacuoles during incubation at 25 °C (Fig. 2) does not decline to as large an extent as would be expected from the shape of the downward phase of counterflow curves (Fig. 1). Thus, it appears that only a fraction of this internal phosphate is mobile. To follow both uptake of [32P]phosphate by counterflow and net efflux of mobile phosphate from the vacuoles the following experiments were performed in parallel. Vacuoles were equilibrated for 30 min at 25 °C with 40 mM potassium phosphate in buffered sorbitol, then the suspension was diluted 40-fold into buffered sorbitol lacking phosphate. In one set of experiments, tracer [32P]phosphate was added to the equilibration buffer (to follow efflux), while in the other it was added to the dilution buffer (to follow counterflow).

The results of the counterflow experiments are shown in Fig. 3A. Rapid uptake of [32P]phosphate is observed, leading to a 17-fold concentration of [32P]phosphate inside the vacuoles at the peak. After this point there is net release of radioactivity. The results of the efflux experiments are shown in Fig. 3B. In this case, movement of [32P]phosphate reflects the overall movement of phosphate out of the vacuoles. Over 90% of the radioactivity associated with the vacuoles is released upon dilution.


Fig. 3. Counterflow and efflux experiments after equilibration of vacuoles with phosphate. Vacuoles were equilibrated for 30 min at 25 °C in 40 mM potassium phosphate, 0.6 M sorbitol, 5 mM Tris-PIPES, pH 6.7, at a concentration of 6 × 109 vacuoles/ml. An additional 4 mM phosphate was released from vacuolar contents during the course of the 30-min incubation. After equilibration, the vacuoles were diluted 40-fold in 0.6 M sorbitol, 5 mM Tris-PIPES, pH 6.6. A, 11 µCi/ml [32P]phosphate was added to the dilution buffer. Points marked by × and open circle  are from independent experiments. B, 245 µCi/ml [32P]phosphate was added to the equilibration buffer. The dilution buffer contained either no added phosphate (+, ×; two independent experiments), 4 mM phosphate (triangle ), or 20 mM phosphate (black-diamond ). 200-µl aliquots were removed at time points and vacuoles were collected by centrifugation and vacuole-associated radioactivity measured as described under "Experimental Procedures." Theoretical curves drawn through the points were constructed as described under "Experimental Procedures" using parameter values of K = .42 mM, R12 = 0.2, R21 = 1, and Ree = 0.0001 mM-1 min-1. An adjustment for unreleased radioactivity of 4000 cpm was added to the counterflow and efflux (with no added phosphate) curves. The internal volume of the vacuoles was estimated to be .07 µl/107 vacuoles by the extrapolation to time 0 of the fraction of total radioactivity trapped inside the vacuoles in the efflux experiments. Similar effects of addition of 20 mM unlabeled phosphate on [32P]phosphate efflux were observed in experiments with three different vacuole preparations.
[View Larger Version of this Image (17K GIF file)]

In principle, the counterflow exchange and the unidirectional efflux could be mediated by two distinct transporters; however, these data can be explained most simply by postulating a single transporter. This transporter can be described using a simple mobile carrier model in which a carrier exists in two distinct states corresponding to its binding of substrate at two faces of the membrane (28). An important parameter in this model is K, the intrinsic dissociation constant for the phosphate-carrier complex. The value of K is readily obtained from the height of the peak of counterflow. The following relation can be derived (28),
K=<FR><NU>P<SUB>1</SUB>−(S<SUB>1</SUB>/S<SUB>2</SUB>)P<SUB>2</SUB></NU><DE>(S<SUB>1</SUB>/S<SUB>2</SUB>)−1</DE></FR> (Eq. 1)
where P1 is the concentration of phosphate inside the vacuoles at the peak of counterflow, P2 is the concentration of phosphate outside, and S1/S2 is the ratio of the concentrations of [32P]phosphate inside and outside. From Fig. 3, P1 is 25 mM, S1/S2 is 17, and P2 is 1.1 mM. From these values, we obtain K ~ 0.4 mM. Theoretical curves based on this model are plotted through the experimental data points in Fig. 3.

We compared the rates of unidirectional efflux versus exchange of phosphate by adding unlabeled KPi to the dilution buffer in the radioactive efflux experiments described above (Fig. 3B). The rate of exit of radioactivity increased dramatically in a concentration-dependent manner. From the model described above, we obtain a Vmax for zero-trans efflux of phosphate from the vacuoles of at least 40 nmol/mg protein/min, while Vmax for equilibrium exchange must be at least five times larger.

Uptake of [32P]phosphate by counterflow should depend on the presence of phosphate inside the vacuoles. Accordingly, no significant uptake of radioactivity is seen if the phosphate gradient across the vacuolar membrane is allowed to dissipate by diluting the vacuoles in buffered sorbitol and incubating them at 25 °C for 30 min before adding [32P]phosphate (data not shown). As an additional control, vacuoles were equilibrated in a small volume of buffered sorbitol containing 40 mM KPi, 40 mM KCl, or no addition, then diluted into buffer containing [32P]phosphate (Fig. 4). Vacuoles equilibrated with phosphate gave a large peak of uptake of [32P]phosphate, while vacuoles preincubated without added phosphate gave only a small amount of uptake, presumably driven by the low levels of endogenous phosphate remaining inside the vacuoles after equilibration.


Fig. 4. Counterflow uptake after equilibration of vacuoles with phosphate or chloride. Vacuoles were equilibrated for 30 min at 25 °C in 0.6 M sorbitol, 5 mM Tris-PIPES, pH 6.7, containing 40 mM KPi, 40 mM KCl, or no added salt, as indicated. After equilibration, the vacuoles were diluted 40-fold into 0.6 M sorbitol, 10 mM Tris-PIPES, pH 6.5, containing 8 µCi/ml [32P]phosphate and added KPi or KCl such that the final composition of the buffer outside the vacuoles after dilution was the same in all three cases. Results from two independent experiments are shown.
[View Larger Version of this Image (25K GIF file)]

A prediction of the model is that addition of unlabeled phosphate to the exterior of the vacuoles during a counterflow experiment should lead to a decrease in the height of the peak of uptake of radioactivity and a shift of this peak to earlier times, due to the combined effects of competitive inhibition of uptake of [32P]phosphate and the increased rate of efflux of radioactivity described above. Addition of phosphate at different concentrations to the exterior of the vacuoles during counterflow experiments leads to the behavior predicted by the model (Fig. 5).


Fig. 5. Effect of addition of external phosphate on uptake by counterflow. [32P]Phosphate uptake experiments were performed as described under "Experimental Procedures." Potassium phosphate was added at concentrations of 0.1, 0.2, 0.5, 1, 2, or 5 mM as indicated, or 2 mM sodium arsenate was added. All solutions were at pH 6.5. An additional 140 µM phosphate was released from vacuolar contents over the course of the 30-min incubation.
[View Larger Version of this Image (28K GIF file)]

Properties of Phosphate Transport

Both uptake of [32P]phosphate by counterflow and efflux of preloaded [32P]phosphate are blocked at 0 °C (data not shown). Uptake of [32P]phosphate is not inhibited by either 100 µM DIDS, an inhibitor of the erythrocyte anion exchange protein band 3, or by carbonyl cyanide p-chlorophenylhydrazone, a protonophore, or by 10 mM EDTA. The pH dependence of uptake was measured over a range of pH values from 5.5 to 7.3 (Fig. 6). It has previously been shown that isolated vacuoles are unstable outside of this range (17). The initial rate of uptake by counterflow increased substantially with decreasing pH.


Fig. 6. pH dependence of phosphate uptake. [32P]Phosphate uptake experiments were performed as described under "Experimental Procedures." Vacuoles were diluted into 0.6 M sorbitol buffered to different pH values with 5 mM Tris-PIPES for pH > 6.5 or 5 mM MES-Tris for pH < 6.5. Initial uptake rates were determined based on radioactivity taken up in 5 min, and are expressed as percent of uptake at pH 5.55. Points are the average of three independent experiments, ± S.E.
[View Larger Version of this Image (14K GIF file)]

Specificity

The transporter appears to be very specific for phosphate. If a given ion is a substrate of the transporter, then its addition to the outside of the vacuoles should have an effect on [32P]phosphate counterflow uptake similar to that of addition of unlabeled phosphate (Fig. 5). If a substance is not a substrate for the transporter but is a competitive inhibitor of phosphate transport, its addition should lower the initial rate of uptake of [32P]phosphate. Addition of 2 mM arsenate to the external buffer during [32P]phosphate uptake experiments has the same effect as addition of 2 mM phosphate (Fig. 5), suggesting that arsenate is a substrate of the transporter. Arsenate is an analog of phosphate with a similar structure. Other inorganic anions do not appear to be recognized by the transporter. Addition of a large excess (20 mM) of Na2SO4 or chloride salts does not inhibit uptake of [32P]phosphate. In fact, salts appear to stimulate uptake nonspecifically, as the addition of potassium gluconate, sodium gluconate, KCl, NaCl, choline chloride, or Na2SO4 all lead to an increased initial rate of uptake. This may be due to effects of ionic strength. Finally, the results shown in Fig. 4 suggest that internal chloride cannot drive uptake of [32P]phosphate by counterflow, consistent with chloride not being a substrate of this transporter.

Next, a number of phosphate-containing compounds were assayed for their ability to inhibit [32P]phosphate uptake. Neither pyridoxal phosphate, glucose 6-phosphate, nor ATP at 5 mM, nor pyrophosphate at 2 mM show any inhibition, although addition of unlabeled phosphate to these concentrations nearly abolishes uptake of [32P]phosphate. Furthermore, neither [32P]pyrophosphate nor [alpha -32P]ATP are taken up by vacuoles when added under the same conditions in which counterflow uptake of [32P]phosphate is observed (data not shown).

Experiments with Vacuolar Membrane Vesicles

Previous studies of vacuolar transport systems have used either isolated intact vacuoles or right-side-out vacuolar membrane vesicles formed by hypotonic lysis of vacuoles (32). We extended our investigation of vacuolar phosphate transport by also performing transport assays with such vesicles.

It has been shown that chloride ion can be transported into vacuolar membrane vesicles at the expense of the positive-inside membrane potential set up by the vacuolar H+-ATPase (24). We tested whether a similar membrane-potential-driven uptake of [32P]phosphate into vesicles could be observed. Under conditions in which there is ATP-dependent uptake of 45Ca due to the action of the Ca2+/H+ exchanger (14) and in which fluorescence quenching of the dye Oxonol-V indicates that a membrane potential is formed (24), no substantial uptake of [32P]phosphate is observed (Fig. 7). Similarly, we saw no ATP-driven uptake of [32P]phosphate into intact vacuoles for which uptake by counterflow had been abolished by allowing the phosphate gradient across the vacuolar membrane to dissipate (data not shown). These results suggest that phosphate does not simply equilibrate with membrane potential as chloride appears to and argue against the existence of an electrical uniport for phosphate (33).


Fig. 7. Uptake of [45Ca]Ca2+ or [32P]phosphate by vacuolar membrane vesicles. Vesicles (100 µg of protein/ml) were incubated in buffer containing 20 mM MES-Tris, pH 6.7, 4 mM MgCl2, 20 mM KCl, 0.6 mM ATP, and 0.25 mM [45Ca]CaCl2 (2 Ci/mol), 1 mM [32P]KPi (8.3 Ci/mol), or 0.1 mM [32P]KPi (93 Ci/mol). 100-µl aliquots were removed at time points, diluted in 4.5 ml of ice-cold wash buffer (10 mM MES-Tris, pH 6.7, 5 mM MgCl2, 25 mM KCl), filtered on nitrocellulose filters, and washed with 10 ml of wash buffer. black-square, 45Ca; black-triangle, 45Ca + 2 µM bafilomycin A1 (an inhibitor of the vacuolar H+-ATPase); square , 1 mM [32P]phosphate; Delta , 0.1 mM [32P]phosphate.
[View Larger Version of this Image (13K GIF file)]

Next, we tested whether the counterflow and efflux behavior seen with intact vacuoles could be recapitulated in vesicles. Vesicles were equilibrated with buffer containing 50 mM phosphate, then diluted into buffer lacking phosphate. Tracer [32P]phosphate was added to either the equilibration buffer or the dilution buffer to follow efflux or counterflow, respectively (Fig. 8). Again, a pattern suggestive of counterflow is observed. In comparison with the results obtained with intact vacuoles, the peak of vesicle-associated [32P]phosphate is reached more rapidly. This can be explained by the smaller trapped volume inside the vesicles. The smaller signal due to this reduced trapped volume was probably also responsible for a variability in results between experiments that was not seen with intact vacuoles. Efflux proceeds on a time scale similar to counterflow (Fig. 8).


Fig. 8. Counterflow and efflux with vacuolar membrane vesicles. Vesicles (74 µg of protein) were diluted into 5 ml of buffer (50 mM KPi, pH 6.7, 24 mM sucrose) and left on ice overnight. The vesicles were collected by centrifugation at 37,000 × g and resuspended in 20 µl of the same buffer. The vesicles were then diluted in 1.85 ml of buffer containing 76 mM potassium gluconate, 5 mM MgCl2, 5 mM MES-Tris, pH 6.7, prewarmed to 30 °C. 250-µl aliquots were removed at time points and added to 4.5 ml of ice-cold 0.1 M LiCl, rapidly filtered on nitrocellulose filters, and washed with 10 ml of cold 0.1 M LiCl. For counterflow experiments, 4 µCi/ml [32P]phosphate was added to the dilution buffer. For efflux experiments, 400 µCi/ml [32P]phosphate was added to the 20 µl of buffer in which vesicles were resuspended, and vesicles were equilibrated for 15 min at room temperature before dilution into buffer lacking radioactivity. The left axis is for counterflow (square ), while the right axis is for efflux (bullet ). Similar results were obtained in two independent experiments for counterflow, and five independent experiments for efflux.
[View Larger Version of this Image (18K GIF file)]


DISCUSSION

We report here the characterization of a phosphate transporter in the vacuolar membrane of yeast. This transporter mediates bidirectional transport and has a millimolar affinity for phosphate. We were able to observe a large uptake of [32P]phosphate due to the presence in isolated yeast vacuoles of a pool of phosphate that provides a large although transient driving force for uptake via exchange.

In the yeast cell, the direction of net movement of phosphate across the vacuolar membrane depends on physiological conditions. When metabolic requirements for phosphate exceed what can be obtained from outside the cell, vacuolar polyphosphate pools are mobilized to replenish cytoplasmic phosphate (10, 11, 34). Several exopolyphosphatases have been identified in the vacuole (35, 36), where they can act to release phosphate from polyphosphate by hydrolysis. The released phosphate then moves out of the vacuole (10). This phosphate efflux may be mediated by the transporter that we have identified, although as previously noted, it is possible that the efflux and exchange activities we have observed are due to two distinct transporters. In the absence of any specific inhibitors of these activities, this possibility cannot be excluded.

Conversely, under conditions where phosphate and metabolic energy are available, and especially when phosphate is added to cells previously starved for phosphate, polyphosphate is synthesized (2, 37). However, the mechanism of polyphosphate synthesis and the vacuolar transport processes required for this synthesis are not clear. Polyphosphate synthesis requires a high energy phosphate donor rather than simply orthophosphate. This donor has not been definitively identified (38), but it presumably must be transported into the vacuole during periods of polyphosphate synthesis.

In vivo studies of phosphate metabolism in yeast conducted using 31P-nuclear magnetic resonance (NMR) (10, 11, 33, 37), as well as studies using differential extraction techniques to distinguish vacuolar and cytoplasmic ion pools (7) have suggested that a large vacuole-to-cytoplasm gradient of phosphate concentration can exist. However, we have found no evidence for active ATP-driven transport of phosphate across the vacuolar membrane similar to that seen for other substances located in the vacuole.

To satisfy conditions of electroneutrality, the efflux of phosphate from vacuoles that we observe must be accompanied by either cation efflux or inward movement of another anion. Since the only anion added to the outside of the vacuoles is the large buffer anion PIPES, the latter possibility seems unlikely. Rather, a vacuolar cation presumably moves out with phosphate, either through the same transporter or in parallel through a separate transporter, e.g. the cation channel previously identified in the vacuolar membrane (18, 19). The fact that we could not observe any membrane potential-driven phosphate uptake suggests that the phosphate carrier itself may perform electroneutral transport.

It should be noted that the vacuoles used in our experiments were all obtained from cells grown in medium containing ample free phosphate. Thus, the transporter does not appear to require phosphate starvation for its induction, like Pho84p, but rather is present constitutively.

There is a striking stimulation of counterflow uptake as the pH is lowered from 7.3 to 5.5. This may suggest that the univalent form of phosphate is the substrate of this carrier, as is the case for the plasma membrane phosphate transporters (6).

Most of the transporters identified in the vacuolar membrane to date have been studied using vacuolar membrane vesicles. The majority of these transporters mediate active uptake driven by the H+-ATPase; this is probably a reflection of the fact that passive transport is difficult to observe in vesicles, given their small internal volume and the fact that they are largely devoid of vacuolar contents (32). With intact vacuoles, in contrast, passive transport systems can be discovered and analyzed more easily (25). Thus, using intact vacuoles we were able to observe and characterize a transporter which mediates passive transport of phosphate across the vacuolar membrane.


FOOTNOTES

*   This work was supported in part by National Institutes of Health Grant HL 08893.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported by a Howard Hughes Medical Institute Predoctoral Fellowship. To whom correspondence should be addressed. Present address: Rosenstiel Center, Brandeis University, Waltham MA 02254-9110. Tel.: 617-736-2470; Fax: 617-736-2405; E-mail: booth{at}hydra.rose.brandeis.edu.
1   The abbreviations used are: PIPES, 1,4-piperazinediethanesulfonic acid; NMR, nuclear magnetic resonance; MES, 2-(N-morpholino)ethanesulfonic acid; KPi, potassium phosphate; DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.

ACKNOWLEDGEMENTS

We are grateful to Dr. Hans-Peter Feidler of the University of Tübingen for his kind gift of bafilomycin A1 and Dr. Anthony Morielli for critical reading of the manuscript.


REFERENCES

  1. Lenburg, M. E., and O'Shea, E. K. (1996) Trends Biochem. Sci. 21, 383-387 [CrossRef][Medline] [Order article via Infotrieve]
  2. Harold, F. M. (1966) Bacteriol. Rev. 30, 772-794 [Medline] [Order article via Infotrieve]
  3. Vogel, K., and Hinnen, A. (1990) Mol. Microbiol. 4, 2013-2017 [Medline] [Order article via Infotrieve]
  4. Bun-Ya, M., Nishimura, M., Harashima, M., and Oshima, Y. (1991) Mol. Cell. Biol. 11, 3229-3238 [Medline] [Order article via Infotrieve]
  5. Tamai, Y., Toh-E, A., and Oshima, Y. (1985) J. Bacteriol. 164, 964-968 [Medline] [Order article via Infotrieve]
  6. Borst-Pauwels, G. W. F. H. (1981) Biochim. Biophys. Acta 650, 88-127 [Medline] [Order article via Infotrieve]
  7. Okorokov, L. A., Lichko, L. P., and Kulaev, I. S. (1980) J. Bacteriol. 144, 661-665 [Medline] [Order article via Infotrieve]
  8. Urech, K., Dürr, M., Boller, T., Wiemken, A., and Schwencke, J. (1978) Arch. Microbiol. 116, 275-278 [Medline] [Order article via Infotrieve]
  9. Kornberg, A. (1995) J. Bacteriol. 177, 491-496 [Abstract]
  10. Nicolay, K., Scheffers, W. A., Bruinenberg, P. M., and Kaptein, R. (1983) Arch. Microbiol. 134, 270-275 [Medline] [Order article via Infotrieve]
  11. Gillies, R. J., Ugurbil, K., den Hollander, J. A., and Shulman, R. G. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 2125-2129 [Abstract]
  12. Klionsky, D. J., Herman, P. K., and Emr, S. D. (1990) Microbiol. Rev. 54, 266-292
  13. Kakinuma, Y., Ohsumi, Y., and Anraku, Y. (1981) J. Biol. Chem. 256, 10859-10863 [Abstract/Free Full Text]
  14. Ohsumi, Y., and Anraku, Y. (1983) J. Biol. Chem. 258, 5614-5617 [Abstract/Free Full Text]
  15. Cunningham, K. W., and Fink, G. R. (1994) J. Exp. Biol. 196, 157-166 [Abstract/Free Full Text]
  16. Sato, T., Ohsumi, Y., and Anraku, Y. (1984) J. Biol. Chem. 259, 11505-11508 [Abstract/Free Full Text]
  17. Boller, T., Dürr, M., and Wiemken, A. (1975) Eur. J. Biochem. 54, 81-91 [Abstract]
  18. Bertl, A., and Slayman, C. L. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 7824-7828 [Abstract]
  19. Wada, Y., Ohsumi, Y., Tanifuji, M., Kasai, M., and Anraku, Y. (1987) J. Biol. Chem. 262, 17260-17263 [Abstract/Free Full Text]
  20. Kakinuma, Y., Masuda, N., and Igarashi, K. (1992) Biochim. Biophys. Acta 1107, 126-130 [Medline] [Order article via Infotrieve]
  21. Li, Z. S., Szczypka, M., Lu, Y.-P., Thiele, D. J., and Rea, P. A. (1996) J. Biol. Chem. 271, 6509-6517 [Abstract/Free Full Text]
  22. Schwencke, J., and De Robichon Szulmajster, H. (1976) Eur. J. Biochem. 65, 49-60 [Abstract]
  23. Nagy, M. (1979) Biochim. Biophys. Acta 558, 221-232 [Medline] [Order article via Infotrieve]
  24. Wada, Y., Ohsumi, Y., and Anraku, Y. (1992) Biochim. Biophys. Acta 1101, 296-302 [Medline] [Order article via Infotrieve]
  25. Boller, T., Dürr, M., and Wiemken, A. (1989) Methods Enzymol. 174, 504-518 [Medline] [Order article via Infotrieve]
  26. Wiemken, A., Schellenberg, M., and Urech, K. (1979) Arch. Microbiol. 123, 23-35
  27. Ames, B. (1966) Methods Enzymol. 8, 115-117
  28. Stein, W. D. (1986) Transport and Diffusion across Cell Membranes, Academic Press, Orlando, FL
  29. Roberts, C. J., Raymond, C. K., Yamashiro, C. T., and Stevens, T. H. (1991) Methods. Enzymol. 194, 644-661 [Medline] [Order article via Infotrieve]
  30. Wiemken, A. (1975) Methods Cell Biol. 12, 99-109 [Medline] [Order article via Infotrieve]
  31. Dürr, M., Urech, K., Boller, T., Wiemken, A., Schwencke, J., and Nagy, M. (1979) Arch. Microbiol. 121, 169-175
  32. Ohsumi, Y., and Anraku, Y. (1981) J. Biol. Chem. 256, 2079-2082 [Abstract/Free Full Text]
  33. Bourne, R. M. (1991) Biochim. Biophys. Acta 1067, 81-88 [Medline] [Order article via Infotrieve]
  34. Bostian, K. A., Lemire, J. M., and Halvorson, H. O. (1983) Mol. Cell. Biol. 3, 839-853 [Medline] [Order article via Infotrieve]
  35. Wurst, H., Shiba, T., and Kornberg, A. (1995) J. Bacteriol. 177, 898-906 [Abstract]
  36. Andreeva, N. A., Lichko, L. P., Kulakovskaia, T. V., and Okorokov, L. A. (1993) Biokhimiia 58, 1053-1061 [Medline] [Order article via Infotrieve]
  37. Bourne, R. M. (1990) Biochim. Biophys. Acta 1055, 1-9 [Medline] [Order article via Infotrieve]
  38. Booth, J. W., and Guidotti, G. (1995) J. Biol. Chem. 270, 19377-19382 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.